Daily FNArena News - Small Caps

All | Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | SMSFundamentals | Technicals | Treasure Chest

Previous Stories

Botswana Coal Resource Makes Nimrodel A Stand-Out

Dec 19 2011

DJ Carmichael has initiated coverage on Nimrodel Resources with a Spec Buy rating, seeing upside from a significant coal resource at the Takatokwane coal project in Botswana.


Bell Potter Remains Positive On Oz Life Sciences Stocks

Dec 13 2011

Bell Potter’s Life Sciences Index is well down this year but the broker continues to see value, offering its top picks in the sector.


Canadian Upside For Mako Energy

Dec 09 2011

DJ Carmichael has initiated coverage on Mako Energy with a Spec Buy rating, attracted to the potential of the group’s two projects in Canada and likely positive news flow in coming months.


Asia Embraces Algae.Tec

Dec 05 2011

As Algae.Tec’s carbon capture and biofuel production technology moves towards production at its Australian showcase facility, a Sri Lankan company has signed Algae.Tec’s first commercial deal in Asia.


Several Reasons To Like Bathurst Resources

Dec 05 2011

While permit approvals offer some risk, high quality output and M&A potential lead Citi to initiate coverage on coal junior Bathurst Resources with a Buy rating.


Is Retail Food Group Undervalued?

Dec 02 2011

An attractive franchise model and a resilient category should support earnings for Retail Food Group, reports UBS.


Fiji Project Makes Amex Resources A Buy

Nov 25 2011

Amex Resources is developing the Mba Delta Iron sand project in Fiji and DJ Carmichael initiates with a Buy rating, seeing significant upside potential as the project moves towards production.


US Potential Makes Breville A Buy

Nov 11 2011

Subdued domestic operating conditions don’t detract from the value on offer in Breville according to Moelis.


Prima Biomed And The Topic Of Cancer

Nov 10 2011

Nomura has initiated coverage on Prima Biomed with a Buy rating, attracted to the group’s potential to develop an immunotherapy-based treatment for ovarian cancer.


Ampella Attracting Interest

Oct 27 2011

With RBS Australia initiating coverage on Apella Mining it brings to three the number of brokers researching the gold junior, all of which rate the company as a Buy.



Analyse The Market From A Different Angle